Neue Suche | Kongressdetail
mail
Druckansicht
 
 

6th Microbiome Movement - Drug Development Summit Europe

Evvnt Promotion / evvnt
-
25.01.2022 - 27.01.2022  The Tower Hotel, St Katharine's Way, E1W 1LD Greater London, England, Großbritannien
Time: 10:00 to 17:50
 
Kongressthemen
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/919896-3?pid=4832

Speakers: Charles Bundinof, Strain Discovery and Microbiome Science Lead, IFF, Denise Kelly, Investment Advisor, Seventure, Duncan Peyton, CEO, 4D Pharma PLC, and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/919896-2?pid=4832
Frau Emily Lincoln
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
Drug Developer - Conference Only: GBP 2049.00, Academic - Conference Only: GBP 1649.00, Solution and Service Provider - Conference Only: GBP 2699.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

AMREF - African Medical and Research FoundationHilfswerk AustriaCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÄrzte der WeltÖsterreichisches Rotes KreuzEuropean Public Health Association (EUPHA)Swiss Tropical and Public Health InstituteAnästhesie in Entwicklungsländern e. V.